MYNDF.US MYND Lifesciencs Inc

Healthcare Biotechnology USA Stocks
0.0081 USD
Close of Nov 15, 2026
0.0081 0.0210
Market cap
USD 387K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jul 2024.

Is MYNDF.US undervalued?

Graham number

The Graham number of MYND Lifesciencs Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MYND Lifesciencs Inc fundamental analysis

No fundamental analysis for MYND Lifesciencs Inc yet.

MYND Lifesciencs Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MYND Lifesciencs Inc

MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.

Full company profile